Smoking cessation: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: ==Medications== ===Rimonabant=== Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation ...) |
imported>Robert Badgett m (→Rimonabant) |
||
| Line 1: | Line 1: | ||
==Medications== | ==Medications== | ||
===Rimonabant=== | ===Rimonabant=== | ||
Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a [[meta-analysis]] of [[randomized controlled | Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a [[meta-analysis]] of [[randomized controlled trial]]s by the [[Cochrane Collaboration]].<ref name="pmid17943852">{{cite journal |author=Cahill K, Ussher M |title=Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD005353 |year=2007 |pmid=17943852 |doi=10.1002/14651858.CD005353.pub3}}</ref> However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."<ref name="pmid17943852"/> | ||
==References== | ==References== | ||
Revision as of 07:55, 11 December 2007
Medications
Rimonabant
Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a meta-analysis of randomized controlled trials by the Cochrane Collaboration.[1] However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."[1]
References
- ↑ 1.0 1.1 Cahill K, Ussher M (2007). "Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation". Cochrane Database Syst Rev (4): CD005353. DOI:10.1002/14651858.CD005353.pub3. PMID 17943852. Research Blogging.